Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: A4H325
Term | Name | Level | Count |
---|---|---|---|
GO:0005975 | carbohydrate metabolic process | 3 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0006486 | protein glycosylation | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0036065 | fucosylation | 3 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043413 | macromolecule glycosylation | 3 | 1 |
GO:0070085 | glycosylation | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity | 7 | 12 |
GO:0008417 | fucosyltransferase activity | 5 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016757 | glycosyltransferase activity | 3 | 12 |
GO:0016758 | hexosyltransferase activity | 4 | 12 |
GO:0031127 | alpha-(1,2)-fucosyltransferase activity | 6 | 12 |
GO:0016787 | hydrolase activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.350 |
CLV_NRD_NRD_1 | 76 | 78 | PF00675 | 0.512 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.350 |
CLV_PCSK_SKI1_1 | 165 | 169 | PF00082 | 0.488 |
CLV_PCSK_SKI1_1 | 258 | 262 | PF00082 | 0.326 |
CLV_PCSK_SKI1_1 | 77 | 81 | PF00082 | 0.269 |
DEG_APCC_DBOX_1 | 164 | 172 | PF00400 | 0.435 |
DEG_APCC_DBOX_1 | 257 | 265 | PF00400 | 0.322 |
DEG_APCC_DBOX_1 | 287 | 295 | PF00400 | 0.411 |
DEG_ODPH_VHL_1 | 187 | 200 | PF01847 | 0.399 |
DEG_SPOP_SBC_1 | 28 | 32 | PF00917 | 0.449 |
DOC_CYCLIN_RxL_1 | 199 | 210 | PF00134 | 0.353 |
DOC_CYCLIN_RxL_1 | 74 | 82 | PF00134 | 0.276 |
DOC_MAPK_gen_1 | 221 | 230 | PF00069 | 0.382 |
DOC_MAPK_MEF2A_6 | 223 | 232 | PF00069 | 0.371 |
DOC_MAPK_MEF2A_6 | 258 | 265 | PF00069 | 0.316 |
DOC_MAPK_NFAT4_5 | 258 | 266 | PF00069 | 0.333 |
DOC_PP1_RVXF_1 | 200 | 207 | PF00149 | 0.329 |
DOC_PP2B_LxvP_1 | 196 | 199 | PF13499 | 0.472 |
DOC_USP7_MATH_1 | 28 | 32 | PF00917 | 0.425 |
DOC_USP7_MATH_2 | 112 | 118 | PF00917 | 0.245 |
DOC_WW_Pin1_4 | 172 | 177 | PF00397 | 0.516 |
DOC_WW_Pin1_4 | 247 | 252 | PF00397 | 0.572 |
DOC_WW_Pin1_4 | 56 | 61 | PF00397 | 0.521 |
LIG_14-3-3_CanoR_1 | 211 | 217 | PF00244 | 0.347 |
LIG_14-3-3_CanoR_1 | 288 | 292 | PF00244 | 0.453 |
LIG_14-3-3_CanoR_1 | 46 | 55 | PF00244 | 0.266 |
LIG_AP2alpha_1 | 147 | 151 | PF02296 | 0.501 |
LIG_APCC_ABBA_1 | 203 | 208 | PF00400 | 0.308 |
LIG_APCC_ABBAyCdc20_2 | 202 | 208 | PF00400 | 0.325 |
LIG_BRCT_BRCA1_1 | 297 | 301 | PF00533 | 0.300 |
LIG_BRCT_BRCA1_1 | 96 | 100 | PF00533 | 0.333 |
LIG_BRCT_BRCA1_2 | 297 | 303 | PF00533 | 0.411 |
LIG_EH1_1 | 5 | 13 | PF00400 | 0.306 |
LIG_eIF4E_1 | 224 | 230 | PF01652 | 0.266 |
LIG_EVH1_1 | 179 | 183 | PF00568 | 0.418 |
LIG_EVH1_1 | 62 | 66 | PF00568 | 0.337 |
LIG_EVH1_2 | 63 | 67 | PF00568 | 0.333 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.368 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.546 |
LIG_Integrin_RGD_1 | 141 | 143 | PF01839 | 0.356 |
LIG_LIR_Gen_1 | 143 | 151 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 143 | 147 | PF02991 | 0.360 |
LIG_LIR_Nem_3 | 149 | 154 | PF02991 | 0.334 |
LIG_LIR_Nem_3 | 280 | 285 | PF02991 | 0.266 |
LIG_LIR_Nem_3 | 39 | 44 | PF02991 | 0.344 |
LIG_LIR_Nem_3 | 98 | 104 | PF02991 | 0.342 |
LIG_LYPXL_yS_3 | 104 | 107 | PF13949 | 0.355 |
LIG_MYND_1 | 60 | 64 | PF01753 | 0.367 |
LIG_NRBOX | 167 | 173 | PF00104 | 0.466 |
LIG_PCNA_PIPBox_1 | 153 | 162 | PF02747 | 0.383 |
LIG_PCNA_yPIPBox_3 | 146 | 160 | PF02747 | 0.404 |
LIG_PDZ_Class_2 | 315 | 320 | PF00595 | 0.300 |
LIG_Pex14_1 | 281 | 285 | PF04695 | 0.266 |
LIG_Pex14_1 | 41 | 45 | PF04695 | 0.329 |
LIG_Pex14_2 | 147 | 151 | PF04695 | 0.449 |
LIG_PTB_Apo_2 | 273 | 280 | PF02174 | 0.360 |
LIG_SH2_GRB2like | 285 | 288 | PF00017 | 0.266 |
LIG_SH2_SRC | 23 | 26 | PF00017 | 0.436 |
LIG_SH2_STAP1 | 144 | 148 | PF00017 | 0.411 |
LIG_SH2_STAP1 | 160 | 164 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 144 | 147 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 219 | 222 | PF00017 | 0.337 |
LIG_SH2_STAT5 | 23 | 26 | PF00017 | 0.436 |
LIG_SH2_STAT5 | 285 | 288 | PF00017 | 0.281 |
LIG_SH2_STAT5 | 313 | 316 | PF00017 | 0.300 |
LIG_SH3_3 | 107 | 113 | PF00018 | 0.346 |
LIG_SH3_3 | 177 | 183 | PF00018 | 0.525 |
LIG_SH3_3 | 186 | 192 | PF00018 | 0.536 |
LIG_SH3_3 | 291 | 297 | PF00018 | 0.266 |
LIG_SH3_3 | 299 | 305 | PF00018 | 0.266 |
LIG_SH3_3 | 54 | 60 | PF00018 | 0.465 |
LIG_SH3_3 | 65 | 71 | PF00018 | 0.333 |
LIG_SUMO_SIM_anti_2 | 152 | 158 | PF11976 | 0.404 |
LIG_SUMO_SIM_anti_2 | 259 | 265 | PF11976 | 0.336 |
LIG_WW_2 | 60 | 63 | PF00397 | 0.509 |
MOD_CK1_1 | 131 | 137 | PF00069 | 0.488 |
MOD_CK1_1 | 240 | 246 | PF00069 | 0.513 |
MOD_CK1_1 | 277 | 283 | PF00069 | 0.290 |
MOD_CK2_1 | 28 | 34 | PF00069 | 0.411 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.367 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.677 |
MOD_GlcNHglycan | 238 | 242 | PF01048 | 0.502 |
MOD_GlcNHglycan | 251 | 254 | PF01048 | 0.537 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.538 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.383 |
MOD_GSK3_1 | 36 | 43 | PF00069 | 0.506 |
MOD_N-GLC_1 | 275 | 280 | PF02516 | 0.266 |
MOD_N-GLC_1 | 46 | 51 | PF02516 | 0.361 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.364 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.405 |
MOD_NEK2_1 | 264 | 269 | PF00069 | 0.322 |
MOD_NEK2_1 | 274 | 279 | PF00069 | 0.301 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.605 |
MOD_NEK2_2 | 128 | 133 | PF00069 | 0.466 |
MOD_NEK2_2 | 40 | 45 | PF00069 | 0.326 |
MOD_PIKK_1 | 264 | 270 | PF00454 | 0.442 |
MOD_PIKK_1 | 46 | 52 | PF00454 | 0.264 |
MOD_PKA_2 | 287 | 293 | PF00069 | 0.443 |
MOD_PKA_2 | 36 | 42 | PF00069 | 0.452 |
MOD_Plk_1 | 142 | 148 | PF00069 | 0.419 |
MOD_Plk_1 | 237 | 243 | PF00069 | 0.489 |
MOD_Plk_1 | 275 | 281 | PF00069 | 0.266 |
MOD_Plk_4 | 106 | 112 | PF00069 | 0.405 |
MOD_Plk_4 | 228 | 234 | PF00069 | 0.397 |
MOD_Plk_4 | 36 | 42 | PF00069 | 0.377 |
MOD_ProDKin_1 | 172 | 178 | PF00069 | 0.514 |
MOD_ProDKin_1 | 247 | 253 | PF00069 | 0.570 |
MOD_ProDKin_1 | 56 | 62 | PF00069 | 0.518 |
TRG_DiLeu_BaLyEn_6 | 199 | 204 | PF01217 | 0.358 |
TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.336 |
TRG_ENDOCYTIC_2 | 144 | 147 | PF00928 | 0.359 |
TRG_ER_diArg_1 | 139 | 141 | PF00400 | 0.328 |
TRG_Pf-PMV_PEXEL_1 | 46 | 50 | PF00026 | 0.361 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HYE7 | Leptomonas seymouri | 60% | 99% |
A0A0S4JMG1 | Bodo saltans | 37% | 76% |
A0A1X0P2U6 | Trypanosomatidae | 50% | 99% |
A0A3S5H4T0 | Leishmania donovani | 83% | 100% |
A0A422NY61 | Trypanosoma rangeli | 53% | 100% |
A4HRD1 | Leishmania infantum | 83% | 100% |
C9ZXG6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9ABZ9 | Leishmania major | 83% | 99% |
E9AJ96 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
V5BBV1 | Trypanosoma cruzi | 54% | 100% |